Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Pharmaceutica Sinica ; (12): 223-228, 2012.
Artigo em Chinês | WPRIM | ID: wpr-323054

RESUMO

The paper reports the systematic study on felodipine and its impurities in tablets, to improve its quality standards for the control of the related substances. HPLC-DAD, UPLC-MS, IR and NMR methods were used for the isolation of felodipine and its impurities in tablets, their identification and the zebrafish animal model was used for the analysis of the toxic impurities. In felodipine material and its tablets, three impurities are isolated and identified. They are impurity 1 [dimethyl 4-(2, 3-dichlorophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate], impurity 2 [ethyl methyl 4-(2, 3-dichlorophenyl)-2, 6-dimethylpyridine-3, 5-dicarboxylate] and impurity 3 [diethyl 4-(2, 3-dichlorophenyl)-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate], separately. The result of zebrafish animal model analysis showed that the teratogenic effects of four compounds were: impurity 3 > or = felodipine > impurity 1 > impurity 2, lethal effects were as follows: impurity 2 = impurity 3 > felodipine > or = impurity 1. This study confirmed the toxicity of three impurities in felodipine. According to the results, the paper suggested the amendments to the standard of the medicine and provided the support to the control of impurities in the manufacturing process.


Assuntos
Animais , Anormalidades Induzidas por Medicamentos , Anti-Hipertensivos , Química , Toxicidade , Bloqueadores dos Canais de Cálcio , Química , Toxicidade , Cromatografia Líquida de Alta Pressão , Métodos , Contaminação de Medicamentos , Felodipino , Química , Toxicidade , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Preparações Farmacêuticas , Química , Controle de Qualidade , Espectrofotometria Infravermelho , Comprimidos , Espectrometria de Massas em Tandem , Peixe-Zebra
2.
Acta Pharmaceutica Sinica ; (12): 50-57, 2011.
Artigo em Chinês | WPRIM | ID: wpr-353330

RESUMO

The pharmaceutical ethynylestradiol (EE) is a potent endocrine modulator. Application enlargement of ethynylestradiol in clinics and abuse in livestock farming and fishing make it important to explore ethynylestradiol toxicological action on vertebrate embryonic development and to establish an in vivo method for EE toxicity detection efficiently and conveniently. In the present study, using a model animal zebrafish and 17alpha-ethynylestradiol as a representative compound, we have investigated EE2 teratogenicity, target tissues and target genes on zebrafish embryo. The results show that median teratogenesis concentration (TC50) of EE2 is 0.8 microg x mL(-1), and median lethal dose (LD50) is 3.3 microg x mL(-1). Targets of EE2 action were implicated in brain, eyes, heart, muscle, skeleton, pigment and viscera. Embryonic cardiac arrhythmia caused by EE2 is probably resulted from heart abnormal structure. The embryonic stage sensitive to EE2 mainly started at cleavage and last up to the organogenesis with time-accumulating effect. RT-PCR results indicate that EE2 treatment disturbed gene expression pattern at the early period of zebrafish embryonic development by suppressing transcription of gene boz that promotes brain development, upregulating genes for trunk and tail, such as ntl, spt, shh, and perturbing Nodal signal expression of TGFbeta superfamily, for example, cyc, sqt and oep. Using zebrafish, an efficient in vivo method for quick evaluation of EE toxicity on embryonic development has been developed.


Assuntos
Animais , Anormalidades Induzidas por Medicamentos , Arritmias Cardíacas , Embriologia , Relação Dose-Resposta a Droga , Embrião não Mamífero , Anormalidades Congênitas , Desenvolvimento Embrionário , Etinilestradiol , Toxicidade , Regulação da Expressão Gênica no Desenvolvimento , Teratogênicos , Toxicidade , Peixe-Zebra , Anormalidades Congênitas , Embriologia
3.
Acta Pharmaceutica Sinica ; (12): 928-935, 2011.
Artigo em Chinês | WPRIM | ID: wpr-233074

RESUMO

Aminoglycoside antibiotics, due to their strong antibacterial effects and broad antimicrobial spectra, have been very commonly used in clinical practice in the past half century. However, aminoglycoside antibiotics manifest severe ototoxicity and nephrotoxicity, and are one of top factors in hearing loss. In this study, three members of the aminoglycoside antibiotics family, gentamycin, neomycin and streptomycin, were chosen as the representatives to be investigated for their toxicity to the embryonic development and the larva hair cells in zebrafish, and also to their target genes associated with hearing-related genes. The results showed that: (1) the lethal effect of all three drugs demonstrated a significant dependence on concentration, and the severity order of the lethal effect was streptomycin > neomycin > gentamycin; (2) all the three drugs caused the larva trunk bending in resting state at 5 dpf (day past fertilization), probably due to their ototoxicity in the physical imbalance and postural abnormalities; (3) impairment and reducing of the hair cells were observed in all three cases of drug treatment; (4) four genes, eya1, val, otx2 and dlx6a, which play an important role in the development of hearing organs, showed differential and significant decrease of gene expression in a drug concentration-dependent manner. This study for the first time reports the relevance between the expression of hearing genes and the three ototoxic antibiotics and also proved the feasibility of establishing a simple, accurate, intuitive and fast model with zebrafish for the detection of drug ototoxicity.


Assuntos
Animais , Aminoglicosídeos , Toxicidade , Antibacterianos , Toxicidade , Desenvolvimento Embrionário , Regulação da Expressão Gênica , Gentamicinas , Toxicidade , Células Ciliadas Auditivas , Biologia Celular , Transtornos da Audição , Genética , Metabolismo , Proteínas de Homeodomínio , Metabolismo , Peptídeos e Proteínas de Sinalização Intracelular , Metabolismo , Larva , Sistema da Linha Lateral , Fator de Transcrição MafB , Metabolismo , Modelos Animais , Neomicina , Toxicidade , Proteínas do Tecido Nervoso , Metabolismo , Proteínas Nucleares , Metabolismo , Fatores de Transcrição Otx , Metabolismo , Inibidores da Síntese de Proteínas , Toxicidade , Proteínas Tirosina Fosfatases , Metabolismo , Estreptomicina , Toxicidade , Peixe-Zebra , Embriologia , Proteínas de Peixe-Zebra , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA